Document is current
Any future updates will be listed below
-
Authors
Ansab, Muhammad
Ramzan, Noor Ul Huda
Ishaque, Ghazal
Araib, Eiman
Rath, Shree
Nisa, Farwa
Qasim, Soban Ali
Dilawar, Esha
Sahin, Ibrahim Halil
- License Information
-
More Information
Article History
Received: 17 October 2025
Accepted: 28 January 2026
First Online: 12 February 2026
Declarations
:
: Not applicable.
: All authors reviewed and approved the final manuscript and consent for publication.
: I.H.S. received Advisory Board fees from Pfizer, Seattle Genetics, Guardant Health, GSK, and Lumanity, and was an Invited Speaker for Pfizer and Amgen. All other authors declare no conflicts of interest relevant to the content of this manuscript.
